Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.25811476 |
2 | synaptic vesicle maturation (GO:0016188) | 5.71129025 |
3 | vocalization behavior (GO:0071625) | 5.68682564 |
4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.66868824 |
5 | locomotory exploration behavior (GO:0035641) | 5.62525836 |
6 | synaptic vesicle exocytosis (GO:0016079) | 5.58914199 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.58776598 |
8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.54593724 |
9 | glutamate secretion (GO:0014047) | 5.46550738 |
10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.14425566 |
11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.07318798 |
12 | gamma-aminobutyric acid transport (GO:0015812) | 5.05681423 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.00020444 |
14 | neuron cell-cell adhesion (GO:0007158) | 4.87920120 |
15 | protein localization to synapse (GO:0035418) | 4.82567395 |
16 | neuronal action potential propagation (GO:0019227) | 4.79040489 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.70745354 |
18 | glutamate receptor signaling pathway (GO:0007215) | 4.67645955 |
19 | neurotransmitter secretion (GO:0007269) | 4.63928052 |
20 | synaptic transmission, glutamatergic (GO:0035249) | 4.63688721 |
21 | exploration behavior (GO:0035640) | 4.52122424 |
22 | regulation of synaptic vesicle transport (GO:1902803) | 4.48375492 |
23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.45138741 |
24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43824466 |
25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.41352492 |
26 | cellular potassium ion homeostasis (GO:0030007) | 4.32504334 |
27 | neuron-neuron synaptic transmission (GO:0007270) | 4.20652887 |
28 | layer formation in cerebral cortex (GO:0021819) | 4.16886796 |
29 | central nervous system myelination (GO:0022010) | 4.09808772 |
30 | axon ensheathment in central nervous system (GO:0032291) | 4.09808772 |
31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.09467961 |
32 | proline transport (GO:0015824) | 4.06433916 |
33 | potassium ion homeostasis (GO:0055075) | 4.04841799 |
34 | long-term memory (GO:0007616) | 4.02671564 |
35 | dendritic spine morphogenesis (GO:0060997) | 3.86692260 |
36 | sodium ion export (GO:0071436) | 3.86305710 |
37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86181420 |
38 | positive regulation of membrane potential (GO:0045838) | 3.83757156 |
39 | positive regulation of synapse maturation (GO:0090129) | 3.83121079 |
40 | neuron recognition (GO:0008038) | 3.79993811 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.79125337 |
42 | amino acid import (GO:0043090) | 3.78404248 |
43 | neurotransmitter transport (GO:0006836) | 3.77932510 |
44 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.77381215 |
45 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.72834843 |
46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.69807142 |
47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.68217001 |
48 | postsynaptic membrane organization (GO:0001941) | 3.68028653 |
49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63745403 |
50 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.62556675 |
51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.62447393 |
52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.59511013 |
53 | regulation of synaptic plasticity (GO:0048167) | 3.59391512 |
54 | transmission of nerve impulse (GO:0019226) | 3.59148305 |
55 | * gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57591343 |
56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.56465523 |
57 | serotonin metabolic process (GO:0042428) | 3.52045833 |
58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.51881622 |
59 | presynaptic membrane assembly (GO:0097105) | 3.51461741 |
60 | regulation of neurotransmitter levels (GO:0001505) | 3.51370154 |
61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.49936791 |
62 | axonal fasciculation (GO:0007413) | 3.48380581 |
63 | regulation of neurotransmitter secretion (GO:0046928) | 3.48346995 |
64 | synaptic vesicle endocytosis (GO:0048488) | 3.44276076 |
65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.41951070 |
66 | neuromuscular synaptic transmission (GO:0007274) | 3.39804887 |
67 | regulation of vesicle fusion (GO:0031338) | 3.38965024 |
68 | cell communication by electrical coupling (GO:0010644) | 3.36082611 |
69 | cell differentiation in hindbrain (GO:0021533) | 3.35659505 |
70 | neurotransmitter uptake (GO:0001504) | 3.35332925 |
71 | long-term synaptic potentiation (GO:0060291) | 3.30613624 |
72 | activation of protein kinase A activity (GO:0034199) | 3.30061449 |
73 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.29960549 |
74 | neuronal ion channel clustering (GO:0045161) | 3.27050942 |
75 | cerebellar granule cell differentiation (GO:0021707) | 3.26873083 |
76 | C4-dicarboxylate transport (GO:0015740) | 3.26676157 |
77 | membrane depolarization during action potential (GO:0086010) | 3.26569963 |
78 | presynaptic membrane organization (GO:0097090) | 3.24900860 |
79 | neuromuscular process controlling balance (GO:0050885) | 3.24514465 |
80 | acidic amino acid transport (GO:0015800) | 3.23766634 |
81 | dendrite morphogenesis (GO:0048813) | 3.22664412 |
82 | membrane depolarization (GO:0051899) | 3.21931854 |
83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.19324803 |
84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.17694260 |
85 | primary amino compound metabolic process (GO:1901160) | 3.14701062 |
86 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.14422576 |
87 | innervation (GO:0060384) | 3.14114269 |
88 | regulation of neurotransmitter transport (GO:0051588) | 3.12944823 |
89 | neuromuscular process controlling posture (GO:0050884) | 3.11515345 |
90 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10896350 |
91 | startle response (GO:0001964) | 3.10406346 |
92 | regulation of dendritic spine development (GO:0060998) | 3.10090264 |
93 | cerebellar Purkinje cell layer development (GO:0021680) | 3.09862746 |
94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09340386 |
95 | synapse assembly (GO:0007416) | 3.08601855 |
96 | prepulse inhibition (GO:0060134) | 3.07109635 |
97 | positive regulation of dendritic spine development (GO:0060999) | 3.06351188 |
98 | membrane hyperpolarization (GO:0060081) | 3.06004823 |
99 | learning (GO:0007612) | 3.05286770 |
100 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.04494255 |
101 | response to histamine (GO:0034776) | 3.04486967 |
102 | cellular sodium ion homeostasis (GO:0006883) | 3.03353899 |
103 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.03347803 |
104 | * synaptic transmission (GO:0007268) | 3.03307358 |
105 | behavioral response to cocaine (GO:0048148) | 3.03097376 |
106 | regulation of synaptic transmission (GO:0050804) | 3.01935545 |
107 | glycine transport (GO:0015816) | 2.99637599 |
108 | intraspecies interaction between organisms (GO:0051703) | 2.98503774 |
109 | social behavior (GO:0035176) | 2.98503774 |
110 | response to auditory stimulus (GO:0010996) | 2.97860618 |
111 | neuromuscular process (GO:0050905) | 2.97197373 |
112 | regulation of synapse maturation (GO:0090128) | 2.96058198 |
113 | auditory behavior (GO:0031223) | 2.95680516 |
114 | vesicle transport along microtubule (GO:0047496) | 2.95367630 |
115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95007282 |
116 | potassium ion import (GO:0010107) | 2.94298730 |
117 | long term synaptic depression (GO:0060292) | 2.93347691 |
118 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.93287620 |
119 | L-amino acid import (GO:0043092) | 2.92412277 |
120 | behavioral fear response (GO:0001662) | 2.90860925 |
121 | behavioral defense response (GO:0002209) | 2.90860925 |
122 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.90317639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 5.65579701 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.65745484 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15036160 |
4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.07796679 |
5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06075871 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75457552 |
7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71626634 |
8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71626634 |
9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62053079 |
10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61993861 |
11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57695857 |
12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53987948 |
13 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52019999 |
14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49897051 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45726143 |
16 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38880134 |
17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34677339 |
18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.34383908 |
19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21483130 |
20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20550234 |
21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18898958 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15901176 |
23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.14296700 |
24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.11741547 |
25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.00177574 |
26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.91022251 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90441409 |
28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87879795 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87842519 |
30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79452051 |
31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79077650 |
32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75249797 |
33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70419798 |
34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68495077 |
35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67706903 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53943320 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49757332 |
38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48990965 |
39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47478165 |
40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43687632 |
41 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34889952 |
42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33773997 |
43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32223672 |
44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32141649 |
45 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31711796 |
46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31391399 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30355038 |
48 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29012371 |
49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28535165 |
50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26253257 |
51 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24468562 |
52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23717408 |
53 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22406171 |
54 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21998918 |
55 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21479623 |
56 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21111982 |
57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16486765 |
58 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13970210 |
59 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13842465 |
60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11764999 |
61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11752943 |
62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11646437 |
63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10978103 |
64 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10246978 |
65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09663480 |
66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09432377 |
67 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.08831262 |
68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08454122 |
69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06624420 |
70 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05558449 |
71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04943289 |
72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04930670 |
73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04813792 |
74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01954512 |
75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01163533 |
76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99690435 |
77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99642602 |
78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99552326 |
79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99463953 |
80 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99343613 |
81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99323274 |
82 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98910425 |
83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98307217 |
84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98271719 |
85 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96359994 |
86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96003244 |
87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95241476 |
88 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94800261 |
89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94587495 |
90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94551064 |
91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94513010 |
92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94412193 |
93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94412193 |
94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93735373 |
95 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92958974 |
96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92249959 |
97 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91170852 |
98 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90405027 |
99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89777676 |
100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89513672 |
101 | JUN_21703547_ChIP-Seq_K562_Human | 0.89335488 |
102 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89053292 |
103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88869225 |
104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88618226 |
105 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88368589 |
106 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88284456 |
107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87923389 |
108 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.86992923 |
109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86217509 |
110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.84793781 |
111 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84266758 |
112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82781205 |
113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81951471 |
114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80588807 |
115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.80253835 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.72994222 |
2 | MP0003880_abnormal_central_pattern | 5.19797988 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.29746953 |
4 | MP0004270_analgesia | 3.77907624 |
5 | * MP0009745_abnormal_behavioral_response | 3.48413041 |
6 | MP0009046_muscle_twitch | 3.39178249 |
7 | * MP0002063_abnormal_learning/memory/cond | 3.34674471 |
8 | * MP0002064_seizures | 3.26324386 |
9 | * MP0001968_abnormal_touch/_nociception | 2.90767826 |
10 | MP0005423_abnormal_somatic_nervous | 2.87671680 |
11 | * MP0002572_abnormal_emotion/affect_behav | 2.83088400 |
12 | * MP0002272_abnormal_nervous_system | 2.67077929 |
13 | MP0001486_abnormal_startle_reflex | 2.59387298 |
14 | * MP0002734_abnormal_mechanical_nocicepti | 2.59262424 |
15 | MP0002736_abnormal_nociception_after | 2.55184585 |
16 | MP0002735_abnormal_chemical_nociception | 2.46041650 |
17 | MP0001501_abnormal_sleep_pattern | 2.41344810 |
18 | MP0001440_abnormal_grooming_behavior | 2.24787743 |
19 | MP0003329_amyloid_beta_deposits | 2.10328544 |
20 | * MP0002067_abnormal_sensory_capabilities | 2.06364051 |
21 | * MP0002733_abnormal_thermal_nociception | 2.04738618 |
22 | MP0008569_lethality_at_weaning | 2.00955206 |
23 | MP0009780_abnormal_chondrocyte_physiolo | 1.95394594 |
24 | * MP0001970_abnormal_pain_threshold | 1.94504958 |
25 | MP0004858_abnormal_nervous_system | 1.89708047 |
26 | MP0002184_abnormal_innervation | 1.85989949 |
27 | MP0002822_catalepsy | 1.80696288 |
28 | MP0002557_abnormal_social/conspecific_i | 1.78669755 |
29 | MP0000778_abnormal_nervous_system | 1.76590238 |
30 | MP0006276_abnormal_autonomic_nervous | 1.69818010 |
31 | MP0004811_abnormal_neuron_physiology | 1.67208618 |
32 | MP0001984_abnormal_olfaction | 1.66081420 |
33 | MP0004924_abnormal_behavior | 1.65802848 |
34 | MP0005386_behavior/neurological_phenoty | 1.65802848 |
35 | MP0002909_abnormal_adrenal_gland | 1.64779931 |
36 | MP0003879_abnormal_hair_cell | 1.63773277 |
37 | MP0005646_abnormal_pituitary_gland | 1.59777827 |
38 | MP0004885_abnormal_endolymph | 1.54336922 |
39 | MP0000955_abnormal_spinal_cord | 1.53314610 |
40 | MP0003633_abnormal_nervous_system | 1.45656145 |
41 | * MP0002066_abnormal_motor_capabilities/c | 1.42770273 |
42 | MP0002882_abnormal_neuron_morphology | 1.38728626 |
43 | MP0003787_abnormal_imprinting | 1.30616705 |
44 | MP0001502_abnormal_circadian_rhythm | 1.29841664 |
45 | MP0004142_abnormal_muscle_tone | 1.27015541 |
46 | MP0005645_abnormal_hypothalamus_physiol | 1.24659391 |
47 | MP0003631_nervous_system_phenotype | 1.22140469 |
48 | MP0004145_abnormal_muscle_electrophysio | 1.12890228 |
49 | MP0002837_dystrophic_cardiac_calcinosis | 1.11540711 |
50 | MP0001905_abnormal_dopamine_level | 1.10896471 |
51 | MP0002152_abnormal_brain_morphology | 1.08087827 |
52 | MP0008872_abnormal_physiological_respon | 1.06877994 |
53 | MP0001188_hyperpigmentation | 1.01526199 |
54 | MP0000604_amyloidosis | 1.01008549 |
55 | MP0002229_neurodegeneration | 0.99794422 |
56 | MP0008877_abnormal_DNA_methylation | 0.98126046 |
57 | MP0001986_abnormal_taste_sensitivity | 0.95848181 |
58 | MP0010386_abnormal_urinary_bladder | 0.95305773 |
59 | MP0001529_abnormal_vocalization | 0.95073240 |
60 | MP0002069_abnormal_eating/drinking_beha | 0.94469447 |
61 | MP0005551_abnormal_eye_electrophysiolog | 0.94341566 |
62 | MP0003122_maternal_imprinting | 0.94230346 |
63 | MP0003690_abnormal_glial_cell | 0.92095464 |
64 | MP0005535_abnormal_body_temperature | 0.90483228 |
65 | MP0003632_abnormal_nervous_system | 0.90105120 |
66 | MP0002876_abnormal_thyroid_physiology | 0.88859704 |
67 | MP0001177_atelectasis | 0.88410685 |
68 | * MP0008874_decreased_physiological_sensi | 0.87837777 |
69 | MP0004215_abnormal_myocardial_fiber | 0.87511229 |
70 | MP0004742_abnormal_vestibular_system | 0.84448498 |
71 | MP0001963_abnormal_hearing_physiology | 0.83359039 |
72 | MP0000751_myopathy | 0.82535895 |
73 | MP0000026_abnormal_inner_ear | 0.82243550 |
74 | MP0003075_altered_response_to | 0.82102492 |
75 | MP0003634_abnormal_glial_cell | 0.80607507 |
76 | MP0002653_abnormal_ependyma_morphology | 0.80158541 |
77 | MP0004085_abnormal_heartbeat | 0.79485229 |
78 | MP0004130_abnormal_muscle_cell | 0.78534582 |
79 | MP0000013_abnormal_adipose_tissue | 0.77936538 |
80 | MP0000920_abnormal_myelination | 0.77913359 |
81 | MP0004484_altered_response_of | 0.77842172 |
82 | MP0000569_abnormal_digit_pigmentation | 0.75421430 |
83 | MP0002638_abnormal_pupillary_reflex | 0.73261944 |
84 | MP0003283_abnormal_digestive_organ | 0.72322636 |
85 | MP0002752_abnormal_somatic_nervous | 0.70667562 |
86 | MP0002090_abnormal_vision | 0.70463618 |
87 | MP0004510_myositis | 0.70196485 |
88 | MP0004147_increased_porphyrin_level | 0.68264725 |
89 | MP0003123_paternal_imprinting | 0.67875568 |
90 | MP0001485_abnormal_pinna_reflex | 0.67284154 |
91 | MP0005623_abnormal_meninges_morphology | 0.66882505 |
92 | MP0005394_taste/olfaction_phenotype | 0.65595262 |
93 | MP0005499_abnormal_olfactory_system | 0.65595262 |
94 | MP0000631_abnormal_neuroendocrine_gland | 0.65019080 |
95 | MP0003137_abnormal_impulse_conducting | 0.60230885 |
96 | MP0008961_abnormal_basal_metabolism | 0.59947052 |
97 | MP0004043_abnormal_pH_regulation | 0.59892803 |
98 | MP0005167_abnormal_blood-brain_barrier | 0.57552552 |
99 | MP0006292_abnormal_olfactory_placode | 0.57340129 |
100 | MP0003938_abnormal_ear_development | 0.56825636 |
101 | MP0003172_abnormal_lysosome_physiology | 0.55262046 |
102 | MP0001348_abnormal_lacrimal_gland | 0.54284783 |
103 | MP0001664_abnormal_digestion | 0.54059807 |
104 | MP0003136_yellow_coat_color | 0.53728650 |
105 | MP0010769_abnormal_survival | 0.53557991 |
106 | MP0002082_postnatal_lethality | 0.52399593 |
107 | MP0010770_preweaning_lethality | 0.52399593 |
108 | MP0010234_abnormal_vibrissa_follicle | 0.52149288 |
109 | MP0001943_abnormal_respiration | 0.52037844 |
110 | MP0005253_abnormal_eye_physiology | 0.51794457 |
111 | MP0001299_abnormal_eye_distance/ | 0.51389925 |
112 | MP0003861_abnormal_nervous_system | 0.50997413 |
113 | MP0004233_abnormal_muscle_weight | 0.50442855 |
114 | * MP0003956_abnormal_body_size | 0.49980639 |
115 | MP0009379_abnormal_foot_pigmentation | 0.49698493 |
116 | MP0005187_abnormal_penis_morphology | 0.48041693 |
117 | MP0010768_mortality/aging | 0.47985961 |
118 | MP0002160_abnormal_reproductive_system | 0.47668005 |
119 | MP0001346_abnormal_lacrimal_gland | 0.46637289 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.71172900 |
2 | Myokymia (HP:0002411) | 6.59515759 |
3 | Focal seizures (HP:0007359) | 6.21595636 |
4 | Visual hallucinations (HP:0002367) | 5.82019569 |
5 | Epileptic encephalopathy (HP:0200134) | 5.30515477 |
6 | Progressive cerebellar ataxia (HP:0002073) | 5.02065212 |
7 | Atonic seizures (HP:0010819) | 4.96443294 |
8 | Febrile seizures (HP:0002373) | 4.95569089 |
9 | Absence seizures (HP:0002121) | 4.54327040 |
10 | Generalized tonic-clonic seizures (HP:0002069) | 4.31711271 |
11 | Action tremor (HP:0002345) | 4.25506643 |
12 | Dialeptic seizures (HP:0011146) | 4.18147759 |
13 | Hyperventilation (HP:0002883) | 3.81051876 |
14 | Gaze-evoked nystagmus (HP:0000640) | 3.77998199 |
15 | Broad-based gait (HP:0002136) | 3.67666532 |
16 | Supranuclear gaze palsy (HP:0000605) | 3.62545733 |
17 | Dysdiadochokinesis (HP:0002075) | 3.55045668 |
18 | Poor eye contact (HP:0000817) | 3.51873969 |
19 | Dysmetria (HP:0001310) | 3.26815749 |
20 | Impaired social interactions (HP:0000735) | 3.21782662 |
21 | Abnormal social behavior (HP:0012433) | 3.21782662 |
22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.21743623 |
23 | Truncal ataxia (HP:0002078) | 3.20752798 |
24 | Depression (HP:0000716) | 3.18366268 |
25 | Genetic anticipation (HP:0003743) | 3.15055685 |
26 | Hemiparesis (HP:0001269) | 3.10440730 |
27 | Diplopia (HP:0000651) | 3.08280854 |
28 | Abnormality of binocular vision (HP:0011514) | 3.08280854 |
29 | Neurofibrillary tangles (HP:0002185) | 3.05530720 |
30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.03937485 |
31 | Anxiety (HP:0000739) | 3.01091085 |
32 | Ankle clonus (HP:0011448) | 3.00434495 |
33 | Cerebral inclusion bodies (HP:0100314) | 2.99998525 |
34 | Hemiplegia (HP:0002301) | 2.99496643 |
35 | Abnormal eating behavior (HP:0100738) | 2.98692399 |
36 | Impaired smooth pursuit (HP:0007772) | 2.97131205 |
37 | Amblyopia (HP:0000646) | 2.96800649 |
38 | Mutism (HP:0002300) | 2.96092223 |
39 | Postural instability (HP:0002172) | 2.90619839 |
40 | Scanning speech (HP:0002168) | 2.88007718 |
41 | Status epilepticus (HP:0002133) | 2.87172955 |
42 | Papilledema (HP:0001085) | 2.84978215 |
43 | Drooling (HP:0002307) | 2.84840605 |
44 | Excessive salivation (HP:0003781) | 2.84840605 |
45 | Epileptiform EEG discharges (HP:0011182) | 2.82764635 |
46 | Abnormality of the lower motor neuron (HP:0002366) | 2.70249891 |
47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.69501786 |
48 | Intention tremor (HP:0002080) | 2.65182440 |
49 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.59629542 |
50 | Cerebral hypomyelination (HP:0006808) | 2.58006239 |
51 | Hypsarrhythmia (HP:0002521) | 2.53153341 |
52 | Bradykinesia (HP:0002067) | 2.51548856 |
53 | Progressive inability to walk (HP:0002505) | 2.50429795 |
54 | Absent speech (HP:0001344) | 2.49463182 |
55 | Spastic gait (HP:0002064) | 2.48836060 |
56 | Stereotypic behavior (HP:0000733) | 2.41409954 |
57 | Dysmetric saccades (HP:0000641) | 2.39320419 |
58 | Agitation (HP:0000713) | 2.38258851 |
59 | Urinary urgency (HP:0000012) | 2.36802472 |
60 | Generalized myoclonic seizures (HP:0002123) | 2.34939119 |
61 | Torticollis (HP:0000473) | 2.33769043 |
62 | Focal dystonia (HP:0004373) | 2.31954117 |
63 | Fetal akinesia sequence (HP:0001989) | 2.24972485 |
64 | Polyphagia (HP:0002591) | 2.24874596 |
65 | Insidious onset (HP:0003587) | 2.24701808 |
66 | Termporal pattern (HP:0011008) | 2.24701808 |
67 | Megalencephaly (HP:0001355) | 2.24508048 |
68 | Impaired vibratory sensation (HP:0002495) | 2.23805195 |
69 | Inability to walk (HP:0002540) | 2.23008580 |
70 | Tetraplegia (HP:0002445) | 2.21307936 |
71 | Sleep apnea (HP:0010535) | 2.21185815 |
72 | Abnormality of the corticospinal tract (HP:0002492) | 2.20932161 |
73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17546621 |
74 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17546621 |
75 | Ventricular fibrillation (HP:0001663) | 2.16389643 |
76 | Pheochromocytoma (HP:0002666) | 2.15140222 |
77 | Confusion (HP:0001289) | 2.11176987 |
78 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07994226 |
79 | Gait ataxia (HP:0002066) | 2.06224274 |
80 | Blue irides (HP:0000635) | 2.05330929 |
81 | Limb dystonia (HP:0002451) | 2.05153305 |
82 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.03472679 |
83 | Lower limb muscle weakness (HP:0007340) | 2.03225449 |
84 | Craniofacial dystonia (HP:0012179) | 1.99624959 |
85 | Psychosis (HP:0000709) | 1.96273580 |
86 | Abnormality of salivation (HP:0100755) | 1.93611190 |
87 | Increased circulating renin level (HP:0000848) | 1.92222378 |
88 | Neuronal loss in central nervous system (HP:0002529) | 1.91596105 |
89 | Incomplete penetrance (HP:0003829) | 1.87861068 |
90 | Obstructive sleep apnea (HP:0002870) | 1.82984168 |
91 | Delusions (HP:0000746) | 1.82820230 |
92 | Abnormality of saccadic eye movements (HP:0000570) | 1.81818381 |
93 | Decreased central vision (HP:0007663) | 1.81648674 |
94 | Gait imbalance (HP:0002141) | 1.81444915 |
95 | Neuroendocrine neoplasm (HP:0100634) | 1.81085648 |
96 | Rigidity (HP:0002063) | 1.80943449 |
97 | Aplasia involving bones of the extremities (HP:0009825) | 1.80251486 |
98 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80251486 |
99 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80251486 |
100 | Lower limb asymmetry (HP:0100559) | 1.80223048 |
101 | Protruding tongue (HP:0010808) | 1.78640782 |
102 | Split foot (HP:0001839) | 1.78568553 |
103 | Specific learning disability (HP:0001328) | 1.78371920 |
104 | Postural tremor (HP:0002174) | 1.77393428 |
105 | Rapidly progressive (HP:0003678) | 1.75961144 |
106 | Akinesia (HP:0002304) | 1.75657586 |
107 | Inappropriate behavior (HP:0000719) | 1.75295172 |
108 | Annular pancreas (HP:0001734) | 1.74565504 |
109 | Insomnia (HP:0100785) | 1.73026336 |
110 | Spastic tetraplegia (HP:0002510) | 1.71030713 |
111 | Generalized hypopigmentation of hair (HP:0011358) | 1.70520823 |
112 | Clonus (HP:0002169) | 1.68860797 |
113 | Spastic tetraparesis (HP:0001285) | 1.67316132 |
114 | Bundle branch block (HP:0011710) | 1.66056688 |
115 | Peripheral hypomyelination (HP:0007182) | 1.64508889 |
116 | Choreoathetosis (HP:0001266) | 1.62759193 |
117 | Abnormal EKG (HP:0003115) | 1.61801974 |
118 | Syncope (HP:0001279) | 1.61460196 |
119 | CNS hypomyelination (HP:0003429) | 1.61452193 |
120 | Prolonged QT interval (HP:0001657) | 1.56754130 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.94487756 |
2 | EPHA4 | 4.45642473 |
3 | MAP3K9 | 3.72648548 |
4 | MAP3K4 | 3.27539776 |
5 | MARK1 | 2.89042365 |
6 | MAP2K7 | 2.87335977 |
7 | MINK1 | 2.62537754 |
8 | DAPK2 | 2.41507951 |
9 | RIPK4 | 2.31469788 |
10 | PAK6 | 2.23405952 |
11 | MAP2K4 | 2.17387038 |
12 | NTRK2 | 2.11646567 |
13 | TNIK | 2.01332845 |
14 | MAP3K12 | 1.99428184 |
15 | NTRK1 | 1.97548229 |
16 | KSR2 | 1.91598481 |
17 | CASK | 1.89055512 |
18 | CAMKK1 | 1.79788463 |
19 | PRKD3 | 1.63902302 |
20 | PNCK | 1.60921300 |
21 | DAPK1 | 1.52050763 |
22 | CDK5 | 1.50686273 |
23 | PLK2 | 1.48591472 |
24 | FES | 1.48069135 |
25 | KSR1 | 1.46612499 |
26 | GRK5 | 1.44556384 |
27 | STK38 | 1.43023304 |
28 | SIK2 | 1.37275962 |
29 | PRKCG | 1.33351630 |
30 | MAPK13 | 1.29363767 |
31 | ARAF | 1.21920552 |
32 | PRPF4B | 1.14757498 |
33 | CDK19 | 1.13368931 |
34 | MAP3K13 | 1.08528776 |
35 | CAMKK2 | 1.05140399 |
36 | PHKG2 | 1.05039182 |
37 | PHKG1 | 1.05039182 |
38 | CAMK2A | 1.04944802 |
39 | MAP3K2 | 1.04209675 |
40 | LATS2 | 1.03218389 |
41 | UHMK1 | 0.99969958 |
42 | PKN1 | 0.95927863 |
43 | BMPR2 | 0.95845920 |
44 | CAMK1 | 0.91614956 |
45 | TYRO3 | 0.91131562 |
46 | CAMK2B | 0.87352108 |
47 | RET | 0.86498476 |
48 | SGK223 | 0.83790341 |
49 | SGK494 | 0.83790341 |
50 | CDK18 | 0.82533824 |
51 | CDK15 | 0.81891064 |
52 | STK11 | 0.80915532 |
53 | SGK2 | 0.79343967 |
54 | CDK14 | 0.78982669 |
55 | PAK3 | 0.77047351 |
56 | PINK1 | 0.76478369 |
57 | MAP3K6 | 0.75476163 |
58 | RAF1 | 0.73598311 |
59 | DYRK1A | 0.72268308 |
60 | TAOK1 | 0.71895481 |
61 | PRKCH | 0.71051404 |
62 | FRK | 0.70732243 |
63 | CDK11A | 0.70048794 |
64 | SGK1 | 0.69817306 |
65 | FER | 0.69079632 |
66 | CSNK1G2 | 0.67681239 |
67 | SGK3 | 0.64198540 |
68 | PDK1 | 0.63613879 |
69 | PTK2B | 0.63588185 |
70 | OXSR1 | 0.63177170 |
71 | LMTK2 | 0.63081237 |
72 | CAMK1G | 0.60044941 |
73 | TNK2 | 0.59950420 |
74 | LIMK1 | 0.59845864 |
75 | ALK | 0.58965678 |
76 | CAMK2D | 0.57853257 |
77 | PRKCE | 0.57584923 |
78 | INSRR | 0.57496238 |
79 | MAP3K1 | 0.57219418 |
80 | PDPK1 | 0.57077334 |
81 | ADRBK2 | 0.55419938 |
82 | MARK2 | 0.54355641 |
83 | MAP3K7 | 0.53509405 |
84 | GRK1 | 0.52764480 |
85 | CDC42BPA | 0.52475327 |
86 | PRKCZ | 0.52061368 |
87 | CAMK2G | 0.51556432 |
88 | DAPK3 | 0.49804581 |
89 | CSNK1G3 | 0.48019430 |
90 | RPS6KA3 | 0.47768728 |
91 | CCNB1 | 0.47188695 |
92 | NME1 | 0.46717964 |
93 | PRKG1 | 0.46643138 |
94 | PRKACA | 0.44461743 |
95 | FGFR2 | 0.44191265 |
96 | NEK6 | 0.43868101 |
97 | PRKG2 | 0.43477648 |
98 | FGR | 0.41967682 |
99 | MAPK12 | 0.40951898 |
100 | FYN | 0.40593963 |
101 | MAPKAPK5 | 0.40514222 |
102 | CSNK1A1L | 0.40209522 |
103 | WNK1 | 0.40204417 |
104 | MAPK10 | 0.39959939 |
105 | SCYL2 | 0.38604757 |
106 | DYRK2 | 0.38517236 |
107 | CAMK4 | 0.38408676 |
108 | CSNK1A1 | 0.38106511 |
109 | ERBB2 | 0.37691473 |
110 | MAP2K1 | 0.37606888 |
111 | RIPK1 | 0.36312178 |
112 | CSNK1D | 0.35976799 |
113 | ROCK1 | 0.35319428 |
114 | CSNK1G1 | 0.35257184 |
115 | BRSK1 | 0.31944394 |
116 | PRKCB | 0.31754851 |
117 | PRKCA | 0.31326345 |
118 | ROCK2 | 0.31258719 |
119 | MAP3K5 | 0.29611460 |
120 | AKT3 | 0.29322560 |
121 | WNK3 | 0.28544140 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.06504492 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.31842636 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82487569 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.79629164 |
5 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.75081671 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.73633964 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.71719475 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.48337330 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44105321 |
10 | * Morphine addiction_Homo sapiens_hsa05032 | 2.37044064 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27851897 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.24001808 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 2.12102665 |
14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09929719 |
15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91374646 |
16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86487781 |
17 | Long-term depression_Homo sapiens_hsa04730 | 1.80022204 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79641695 |
19 | * Taste transduction_Homo sapiens_hsa04742 | 1.79088834 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65001126 |
21 | Renin secretion_Homo sapiens_hsa04924 | 1.63121385 |
22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59102355 |
23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59052906 |
24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56929683 |
25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55663866 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50672246 |
27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45567197 |
28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44487460 |
29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41897402 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39957734 |
31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34966630 |
32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30201908 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28335998 |
34 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21240503 |
35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19819338 |
36 | Gap junction_Homo sapiens_hsa04540 | 1.19676259 |
37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12411123 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10373307 |
39 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06988990 |
40 | Glioma_Homo sapiens_hsa05214 | 1.03329696 |
41 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00656693 |
42 | Melanogenesis_Homo sapiens_hsa04916 | 0.99908673 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98947153 |
44 | Axon guidance_Homo sapiens_hsa04360 | 0.98776397 |
45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95958244 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95765883 |
47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95222642 |
48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93314981 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89435946 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86811734 |
51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84132929 |
52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83632373 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83361685 |
54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81923204 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77934670 |
56 | Bile secretion_Homo sapiens_hsa04976 | 0.74817497 |
57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72085161 |
58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70894563 |
59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70488271 |
60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69610758 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66560478 |
62 | Phototransduction_Homo sapiens_hsa04744 | 0.65915908 |
63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64106436 |
64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62228484 |
65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62099416 |
66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61615805 |
67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60034807 |
68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59961813 |
69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55060833 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53943505 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52279698 |
72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51635014 |
73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49762094 |
74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49757526 |
75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46664447 |
76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46509518 |
77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46069763 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45341955 |
79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45072526 |
80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44347606 |
81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43356308 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42076730 |
83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40781942 |
84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40243713 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39224964 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.37772656 |
87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37236580 |
88 | Mineral absorption_Homo sapiens_hsa04978 | 0.36992144 |
89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36238305 |
90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35539813 |
91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35224725 |
92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34675553 |
93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33586254 |
94 | Alcoholism_Homo sapiens_hsa05034 | 0.32722813 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32343853 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31724493 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30117218 |
98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29833385 |
99 | Endocytosis_Homo sapiens_hsa04144 | 0.28597131 |
100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28111875 |
101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27068401 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.26719033 |
103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.26434841 |
104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25920434 |
105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25662340 |
106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25382569 |
107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24653441 |
108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23836509 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22564095 |
110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.22477098 |
111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19278341 |
112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.11469014 |